Citation Impact
Citing Papers
Hallmarks of Cancer: The Next Generation
2011 Standout
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Genetic effects on gene expression across human tissues
2017 StandoutNature
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
A mitochondrial genome sequence of a hominin from Sima de los Huesos
2013 StandoutNatureNobel
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Inactivation of the serpin α2-antiplasmin by stromelysin-1
2001
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
1998 Standout
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
The contribution of thrombosis to the clinical expression of coronary atherosclerosis
1996
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
2002
Matrix metalloproteinases: effectors of development and normal physiology
2000
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
1990
Atherosclerosis — An Inflammatory Disease
1999 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Increased platelet deposition on atherosclerotic coronary arteries.
1994
Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)
2000
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
1998
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Matrix metalloproteinases: they're not just for matrix anymore!
2001
Matrix metalloproteinases: multifunctional contributors to tumor progression
2000
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Atherosclerosis
2001 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque
1994
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Endogenous Inhibitors of Angiogenesis
2005
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
1994
Serpin Structure, Mechanism, and Function
2002 Standout
Evolution of multilevel caves in the Sierra de Atapuerca (Burgos, Spain) and its relation to human occupation
2012
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
2002 Standout
Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment.
2001
A review on natural and human-induced geohazards and impacts in karst
2014 Standout
Antigenic Tumor Cell Variants Obtained with Mutagens
1983
Nanoparticles in Photodynamic Therapy
2015 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Hyaluronan in Tissue Injury and Repair
2007
Regulation of matrix metalloproteinase expression in tumor invasion
1999 Standout
Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
2000
Immunoglobulin-Receptors Revisited
1975 Science
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
2001
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Atherosclerosis Progression in LDL Receptor–Deficient and Apolipoprotein E–Deficient Mice Is Independent of Genetic Alterations in Plasminogen Activator Inhibitor-1
2000
Coronary Plaque Disruption
1995 Standout
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
1994
Immunological phenotype of lymphomas induced by avian leukosis viruses.
1983 StandoutNobel
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Fibrinogen as a key regulator of inflammation in disease
2011
Fate of fibrinogen in human arterial intima.
1990
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors
1995
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis
2002
Works of A. Bini being referenced
Identification and distribution of fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis
1989
EFFECTS OF THE STRUCTURAL SETTING ON ENDOKARST SYSTEM GEOMETRY IN THE VALLE DEL NOSE (COMO LAKE, NORTHERN ITALY)
2007
Fibrin and the Vessel Wall
1990
Generation of an Angiostatin-like Fragment from Plasminogen by Stromelysin-1 (MMP-3)
1998
Proteolytic Cleavage of Urokinase-Type Plasminogen Activator by Stromelysin-1 (MMP-3)
1998
Polymerization of fibrinogen in murine bleomycin-induced lung injury
1996
Immunologic Cross-Reactivity of Antigen(s) Induced by Drug Treatment in Two Leukemic Sublines
1976
Cave genesis in the Alps between the Miocene and today: a review
2006
Cellular immune response to a drug-treated L5178Y lymphoma subline
1974 Nature
Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
1989